Medical Communications

Showing 15 posts of 6408 posts found.

Bill Gates backed biotech reveals strategy

June 8, 2018 Medical Communications Bill and Melinda Gates Foundation, biotech, drugs, pharma, pharmaceutical

The Bill and Melina Gates Foundation already funnels a large amount of money into aiding public health, particularly by funding …
cancer_research_uk

Cancer Research UK unveil new Chief Business Officer

June 8, 2018 Medical Communications Cancer Research UK, biotech, drugs, pharma, pharmaceutical

Cancer Research UK has appointed Tony Hickson to the position of Chief Business Officer. He arrives to the business from …
nerves

Parkinson’s disease: A quest for steadier therapies

June 7, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Parkinson's disease, biotech, drugs, pharma, pharmaceutical

The worrying number of deaths associated with Nuplazid has eyes returning to the pipeline for Parkinson’s disease. Anjali Shukla, a …

FlyPharma Conference Europe concludes its fourth successful year in Brussels

June 7, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, flypharma, pharma, pharmaceutical

The FlyPharma Conference Europe wrapped up for another year on 6 June, returning with an expanded roster of speakers who …
allergan-irvine-california-2_0

Allergan mauled by investors in public letter

June 6, 2018 Medical Communications, Research and Development Allergan

Last week, Allergan announced that a strategic review of its operations had led to a decision to divest its women’s …
bill_hinshaw

Novartis’ US Oncology head makes leap to become biotech CEO

June 5, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis

The departure of high-level, big pharma executives to tiny biotechs is steadily becoming a constant stream; the latest is Bill …
david_elkins

Celgene bring in new CFO to steady the ship

June 5, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Celgene

The fact that Celgene is currently sailing through choppy waters is no secret to anyone within the industry, it’s facing …
shutterstock_273326141

Axovant snatches Teva and Allergan execs to strengthen management

June 5, 2018 Manufacturing and Production, Medical Communications Allergan, Axovant, Teva, appointment, pharma

Axovant has announced reinforcements to its management team with two new additions, snatching up Allergan’s current Chief Medical Officer Dr …
diana-bracco-100-01

Milan’s decision to appeal the EMA HQ relocation explained

June 4, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Milan, biotech, drugs, pharma, pharmaceutical

The decision to award the EMA headquarters to Amsterdam was a contentious one, not least because the vote had to …
onlinr

Celgene bring in new CFO to steady the ship

June 4, 2018 Medical Communications, Sales and Marketing Celgene, Johnson & Johnson, biotech, drugs, pharma, pharmaceutical

The fact that Celgene is currently sailing through choppy waters is no secret to anyone within the industry, it’s facing …
fda2outsideweb

Kitov’s combo gets FDA approval in osteoarthritis and hypertension

June 1, 2018 Medical Communications, Sales and Marketing Consensi, FDA, Kitov, US, hypertension, osteoarthritis, pharma

Israeli biopharmaceutical firm is celebrating the approval in the US of Consensi, a combo of the calcium channel blocker amlodipine …
bayer_cross_2

Bayer eyes R&D cuts, as Monsanto deal raises question of focus

June 1, 2018 Medical Communications Bayer, biotech, drugs, monsanto, pharma, pharmaceutical

When rumours first started rumbling about a mega-merger between Bayer and Monsanto, one of the major question marks was on …
roche_side_building

Roche resigns itself to failure on SMA drug

June 1, 2018 Medical Communications Roche, biotech, drugs, pharma, pharmaceutical, spinal muscular atrophy

Roche has announced that it will no longer seek to develop its treatment for spinal muscular atrophy (SMA), olesoxime, after …
online

Novartis’ US Oncology head makes leap to become biotech CEO

June 1, 2018 Medical Communications Novartis, axcella, biotech, drugs, pharma, pharmaceutical

The departure of high-level, big pharma executives to tiny biotechs is steadily becoming a constant stream; the latest is Bill …
The Gateway to Local Adoption Series

Latest content